SOPH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SOPHiA GENETICS SA (SOPH) is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. The stock shows positive growth potential based on technical indicators, hedge fund interest, and improving financial performance. Despite a slight pre-market dip, the overall outlook is favorable.
The MACD histogram is positive (0.0287) and contracting, indicating a bullish trend. The RSI is neutral at 43.506, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels suggest the stock is trading near support (S1: 4.623), offering a potential entry point.
Hedge funds are significantly increasing their positions in SOPH (1033.12% increase in buying). Analysts have raised the price target to $7 from $6 with a Buy rating. The stock has an 80% chance of increasing by 5.09% in the next day and 10.61% in the next week.
No significant insider trading activity. Gross margin has slightly declined (-0.84% YoY).
In Q4 2025, revenue increased by 22.41% YoY to $21.71M. Net income improved by 26.53% YoY to -$19.18M, and EPS rose by 21.74% YoY to -0.28. However, gross margin slightly declined to 67.68%.
Guggenheim raised the price target to $7 from $6 and maintained a Buy rating, reflecting confidence in the company's growth potential.
